CY1118727T1 - Φαρμακευτικη συνθεση με φωσφολιπιδιο - Google Patents

Φαρμακευτικη συνθεση με φωσφολιπιδιο

Info

Publication number
CY1118727T1
CY1118727T1 CY20161101165T CY161101165T CY1118727T1 CY 1118727 T1 CY1118727 T1 CY 1118727T1 CY 20161101165 T CY20161101165 T CY 20161101165T CY 161101165 T CY161101165 T CY 161101165T CY 1118727 T1 CY1118727 T1 CY 1118727T1
Authority
CY
Cyprus
Prior art keywords
phospholipid
pharmaceutical composition
composition
concentration
active ingredient
Prior art date
Application number
CY20161101165T
Other languages
English (en)
Inventor
Bernd G Seigfried
Original Assignee
Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh filed Critical Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Publication of CY1118727T1 publication Critical patent/CY1118727T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Περιγράφεται μια φαρμακευτική σύνθεση για την εφαρμογή στον άνθρωπο και στα ζώα, με τουλάχιστον ένα συστημικής ή/και τοπικής δράσης, τοπικώς εφαρμοζόμενο δραστικό συστατικό και με τουλάχιστον ένα φωσφολιπίδιο το οποίο βελτιώνει τη μεταφορά του δραστικού συστατικού μέσω της κυτταρικής μεμβράνης, το οποίο περιέχει φωσφατιδυλοχολίνη σε μια συγκέντρωση τουλάχιστον 60 % κ.β., η οποία αναφέρεται στο φωσφολιπίδιο. Η σύνθεση έχει μια τέτοια υγρή συνοχή ώστε είναι σε θέση να ψεκάζεται ως σταγονίδια ή ως αφρός, όπου η σύνθεση περιέχει ένα τέτοιο φωσφολιπίδιο το οποίο επιπροσθέτως αποτελείται, εκτός από την τουλάχιστον 60 % κ.β. φωσφατιδυλοχολίνη, από έλαιο σε μια συγκέντρωση 7,5 % κ.β. κατά το μέγιστο.
CY20161101165T 2012-05-15 2016-11-14 Φαρμακευτικη συνθεση με φωσφολιπιδιο CY1118727T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012009575 2012-05-15
DE102013004199A DE102013004199A1 (de) 2012-05-15 2013-03-12 Pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
CY1118727T1 true CY1118727T1 (el) 2017-07-12

Family

ID=47901750

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161101165T CY1118727T1 (el) 2012-05-15 2016-11-14 Φαρμακευτικη συνθεση με φωσφολιπιδιο

Country Status (18)

Country Link
EP (1) EP2638894B1 (el)
JP (1) JP2013237669A (el)
BR (1) BR102013011801B1 (el)
CA (1) CA2815477C (el)
CY (1) CY1118727T1 (el)
DE (1) DE102013004199A1 (el)
DK (1) DK2638894T3 (el)
ES (1) ES2606031T3 (el)
HR (1) HRP20161318T1 (el)
HU (1) HUE029793T2 (el)
LT (1) LT2638894T (el)
MX (1) MX342069B (el)
PL (1) PL2638894T3 (el)
PT (1) PT2638894T (el)
RS (1) RS55291B1 (el)
RU (1) RU2659943C2 (el)
SI (1) SI2638894T1 (el)
SM (1) SMT201600419B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0521398T3 (da) * 1991-07-05 1999-07-05 Rhone Poulenc Rorer Gmbh Phospholipidsammensætning
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
AU7977294A (en) * 1993-10-07 1995-05-01 Odontex, Inc. Absorption enhancers for topical pharmaceutical formulations
ES2180599T3 (es) 1994-09-30 2003-02-16 Mika Pharma Ges Fur Die Entwic Composicion farmaceutica.
JP2008514606A (ja) * 2004-09-24 2008-05-08 リポ ケミカルズ インコーポレイテッド 局所適用化合物のためのデリバリーシステム
CA2752849C (en) * 2009-07-24 2014-07-08 Bernd G. Seigfried Liquid compositions capable of foaming and including active agents, and methods for making or developing same

Also Published As

Publication number Publication date
DE102013004199A1 (de) 2013-11-21
CA2815477C (en) 2017-05-02
PL2638894T3 (pl) 2017-02-28
PT2638894T (pt) 2016-12-13
HUE029793T2 (en) 2017-04-28
BR102013011801B1 (pt) 2022-08-09
MX2013005306A (es) 2013-11-26
SI2638894T1 (sl) 2017-01-31
SMT201600419B (it) 2017-01-10
JP2013237669A (ja) 2013-11-28
EP2638894A1 (de) 2013-09-18
DK2638894T3 (en) 2016-10-17
RS55291B1 (sr) 2017-03-31
EP2638894B1 (de) 2016-09-14
HRP20161318T1 (hr) 2016-12-16
RU2013121269A (ru) 2014-11-20
LT2638894T (lt) 2017-02-10
BR102013011801A2 (pt) 2015-11-10
MX342069B (es) 2016-09-13
ES2606031T3 (es) 2017-03-17
CA2815477A1 (en) 2013-11-15
RU2659943C2 (ru) 2018-07-04

Similar Documents

Publication Publication Date Title
CY1123476T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
NI201500167A (es) Compuestos químicos
CY1122838T1 (el) Τοπικες συνθεσεις οι οποιες περιλαμβανουν φιπρονιλη και περμεθρινη και μεθοδοι χρησης
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
MX2016012893A (es) Sustancias terapéuticas combinadas supramoleculares.
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
CO7160052A2 (es) Composiciones pesticidas y procesos relacionados con las mismas
TR201909461T4 (tr) Si̇stemi̇k olarak etki̇ eden akti̇f maddeleri̇ i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
DOP2015000170A (es) Compuestos químicos
BRPI1016228A8 (pt) formulações de eletrólito compatibilizadas
CY1118727T1 (el) Φαρμακευτικη συνθεση με φωσφολιπιδιο
DOP2016000007A (es) Pirazolpiridinas sustituidas
BR112012026659A2 (pt) composto para desinfecção de superfícies.
UA116886C2 (uk) Препаративна форма йодосульфурон-метилу натрієвої солі
ECSP20023626A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
AR101581A1 (es) Composición de colutorio
BR112015000275A2 (pt) utilização de um extrato de mirta como agente anti-biopelícula face p. acnes
BR112014029874A8 (pt) composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica
CY1122694T1 (el) Φαρμακοτεχνικη μορφη η οποια περιεχει κουρκουμινη
CO2020002624A2 (es) Formulación de uso tópico para el control y la prevención de parásitos en animales
CY1121708T1 (el) Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση
BR112016028585A2 (pt) composições herbicidas sólidas contendo um agente de proteção
BR112015022923A2 (pt) derivados de imidazopiridina microbicidamente ativos
AR081879A1 (es) Preparacion que contiene ectoparasiticida para la formacion de emulsion espontanea